These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
145 related items for PubMed ID: 24605355
21. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas. Vermeer MH, Tensen CP, van der Stoop PM, van Oostveen HW, Lund M, Scheper RJ, Willemze R. Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809 [Abstract] [Full Text] [Related]
22. Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes. Kaiser P, Joos B, Niederöst B, Weber R, Günthard HF, Fischer M. J Virol; 2007 Sep; 81(18):9693-706. PubMed ID: 17609262 [Abstract] [Full Text] [Related]
23. High clinical response rate of Sezary syndrome to immunomodulatory therapies: prognostic markers of response. Raphael BA, Shin DB, Suchin KR, Morrissey KA, Vittorio CC, Kim EJ, Gardner JM, Evans KG, Introcaso CE, Samimi SS, Gelfand JM, Rook AH. Arch Dermatol; 2011 Dec; 147(12):1410-5. PubMed ID: 21844430 [Abstract] [Full Text] [Related]
24. Mycosis fungoides/Sézary syndrome: report of an unusual case. Mehta A, Dhungel BM, Khan MF. J Cutan Pathol; 2006 Sep; 33 Suppl 2():12-5. PubMed ID: 16972946 [Abstract] [Full Text] [Related]
25. Sezary cell-like leukemia: a distinct type of mature T cell malignancy. Matutes E, Keeling DM, Newland AC, Scott CS, Mitchell D, Traub N, Wardle DG, Catovsky D. Leukemia; 1990 Apr; 4(4):262-6. PubMed ID: 2366582 [Abstract] [Full Text] [Related]
26. EPHA4 is overexpressed but not functionally active in Sézary syndrome. Hameetman L, van der Fits L, Zoutman WH, Out-Luiting JJ, Siegal G, de Esch IJ, Vermeer MH, Tensen CP. Oncotarget; 2015 Oct 13; 6(31):31868-76. PubMed ID: 26376612 [Abstract] [Full Text] [Related]
28. Immunophenotypic identification of Sezary cells in peripheral blood. Bogen SA, Pelley D, Charif M, McCusker M, Koh H, Foss F, Garifallou M, Arkin C, Zucker-Franklin D. Am J Clin Pathol; 1996 Dec 13; 106(6):739-48. PubMed ID: 8980349 [Abstract] [Full Text] [Related]
29. Skin-homing CD8+ T lymphocytes show preferential growth in vitro and suppress CD4+ T-cell proliferation in patients with early stages of cutaneous T-cell lymphoma. Thestrup-Pedersen K, Parhar R, Wu K, Bertilsson PA, Meyer B, Abu-Amero S, Hainau B, Aleisa A, Alfadley A, Hamadah I, Alajlan A, Al-Hussein K, Al-Mohanna F. Acta Derm Venereol; 2007 Dec 13; 87(2):118-26. PubMed ID: 17340017 [Abstract] [Full Text] [Related]
30. Variable CD7 expression on T cells in the leukemic phase of cutaneous T cell lymphoma (Sézary syndrome). Vonderheid EC, Bigler RD, Kotecha A, Boselli CM, Lessin SR, Bernengo MG, Polansky M. J Invest Dermatol; 2001 Sep 13; 117(3):654-62. PubMed ID: 11564173 [Abstract] [Full Text] [Related]
31. T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings. Ponti R, Quaglino P, Novelli M, Fierro MT, Comessatti A, Peroni A, Bonello L, Bernengo MG. Br J Dermatol; 2005 Sep 13; 153(3):565-73. PubMed ID: 16120144 [Abstract] [Full Text] [Related]
32. Extracutaneous transformation into a high-grade lymphoma: a potential pitfall in the management of patients with Sézary syndrome. Michaelis S, Kazakov DV, Burg G, Dummer R, Kempf W. Int J Dermatol; 2006 Mar 13; 45(3):277-9. PubMed ID: 16533228 [Abstract] [Full Text] [Related]
33. CD4/CD8 double-positive, acute type of adult T-cell leukemia/lymphoma with extensive cutaneous involvement. Kim YJ, Hwang ES, Kim IH, Yu DS. Int J Dermatol; 2006 Oct 13; 45(10):1193-5. PubMed ID: 17040438 [No Abstract] [Full Text] [Related]
34. The diagnosis of Sézary syndrome on peripheral blood by flow cytometry requires the use of multiple markers. Klemke CD, Brade J, Weckesser S, Sachse MM, Booken N, Neumaier M, Goerdt S, Nebe TC. Br J Dermatol; 2008 Sep 13; 159(4):871-80. PubMed ID: 18652582 [Abstract] [Full Text] [Related]
35. Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathologic, immunophenotypic, and molecular study of 22 Asian cases according to WHO-EORTC classification. Kong YY, Dai B, Kong JC, Zhou XY, Lu HF, Shen L, Du X, Shi DR. Am J Surg Pathol; 2008 Oct 13; 32(10):1495-502. PubMed ID: 18708940 [Abstract] [Full Text] [Related]
36. In vivo imaging of cutaneous T-cell lymphoma migration to the skin. Hoeller C, Richardson SK, Ng LG, Valero T, Wysocka M, Rook AH, Weninger W. Cancer Res; 2009 Apr 01; 69(7):2704-8. PubMed ID: 19318575 [Abstract] [Full Text] [Related]
37. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers. Jawed SI, Myskowski PL, Horwitz S, Moskowitz A, Querfeld C. J Am Acad Dermatol; 2014 Feb 01; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969 [Abstract] [Full Text] [Related]
38. Non lymphoblastic T cell lymphomas with prevalent skin involvement different from mycosis fungoides or Sézary's syndrome. A retrospective study of 6 cases in Europe. Grob JJ, Horchowski N, Tubiana N, Gabriel B, Gastaut JA, Hassoun J, Jouve I, Carcassone Y, Bonerandi JJ. Dermatologica; 1988 Feb 01; 177(2):82-97. PubMed ID: 3262542 [Abstract] [Full Text] [Related]
39. CD4/CD8 double negative pagetoid reticulosis: a case report and literature review. Mourtzinos N, Puri PK, Wang G, Liu ML. J Cutan Pathol; 2010 Apr 01; 37(4):491-6. PubMed ID: 19614989 [Abstract] [Full Text] [Related]
40. Expression pattern of chemokine receptors and chemokine release in inflammatory erythroderma and Sézary syndrome. Fierro MT, Comessatti A, Quaglino P, Ortoncelli M, Osella Abate S, Ponti R, Novelli M, Bernengo MG. Dermatology; 2006 Apr 01; 213(4):284-92. PubMed ID: 17135733 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]